GENOME ANNOUNCEMENT {#h0.0}
===================

*Micromonospora* spp. have long been recognized as crucial sources of antibiotics ([@B1]). The aminoglycoside antibiotics gentamicin ([@B2]) and netilmicin ([@B3]), antitumor antibiotics lomaiviticins A and B ([@B4]), tetrocarcins ([@B5][@B6][@B8]), LL-E33288 ([@B9]), anthracycline antibiotics ([@B10]), the anthraquinone lupinacidins A to C ([@B11], [@B12]) and diazepinomicin, an antimicrobial marine alkaloid ([@B13]), are but a few of the medicinally significant secondary metabolites produced by *Micromonospora* spp.; members of the genus have been credited with providing over 700 compounds of medicinal value ([@B1]). Despite this, relative to other actinomycetes, there is a scarcity of genome information on *Micromonospora*.

*Micromonospora* spp. are Gram-positive, generally aerobic, and tend to exhibit complex life cycles, differentiating into both substrate mycelia and spores, although aerial mycelia are not a common feature ([@B14]). The life cycle characteristics, habitats, and both past and putative future applications of these bacteria have been excellently reviewed; notable emphasis now focuses on their use in biofuel production ([@B15]).

To identify new and otherwise cryptic biosynthetic gene clusters and their corresponding bioactive natural products through coculturing methodologies, we recently carried out metabolomics studies involving *Micromonospora* sp. strain WMMB235 in the presence of *Rhodococcus* sp. WMMA-185. *Micromonospora* sp. WMMB235 was isolated in 2011 from a marine-associated ascidian collected off the coast of the Florida Keys.

The complete genome of *Micromonospora* sp. WMMB235 was sequenced at the Duke Center for Genomic and Computational Biology (GCB) using PacBio RSII (Pacific Biosciences) technology. Reads were constructed using the HGAP assembler ([@B16]) into two different contigs that were 7.02 Mb and 14.7 kb in size, respectively. We hypothesize that the smaller of the two contigs is a plasmid, whereas the larger contig represents the full circular chromosome of WMMB235. This logic is supported by a ≈10-kb overlap of the ends of the contig. Within this overlap are five single-base gaps that we have not been able thus far to resolve. The smaller 14-kb contig aligns well with the 3′ end of the larger contig, with the notable exception that it contains a 1,402-bp insert from elsewhere in the genome. Consequently, we do not yet know if this smaller contig represents a real variant sequence of the chromosome or is merely an assembly error.

Open reading frames were predicted by Prodigal ([@B17]) and annotated using HMMer models for the TIGRfam ([@B18]), KEGG ([@B19], [@B20]), and Pfam ([@B21], [@B22]) databases. The genome is 72.83% GC and has 90.27% coding density. The organism's secondary metabolic content/potential was assessed on the basis of antiSMASH ([@B23], [@B24]), PRISM ([@B25]), and custom pipelines. Housed within the *Micromonospora* sp. WMMB235 genome were found a single type I polyketide (PKS), a single type III PKS, one lanthipeptide system ([@B26]), and seven hybrid biosynthetic gene clusters. Thus, genome analysis of WMMB235 has revealed this *Micromonospora* to have a wealth of biosynthetic machineries at its disposal.

Accession number(s). {#s1}
--------------------

This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession no. [MDRX00000000](https://www.ncbi.nlm.nih.gov/nuccore/MDRX00000000). The version described in this paper is version MDRX01000000.
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